|
TWI262914B
(en)
|
1999-07-02 |
2006-10-01 |
Agouron Pharma |
Compounds and pharmaceutical compositions for inhibiting protein kinases
|
|
EP1648455A4
(en)
|
2003-07-23 |
2009-03-04 |
Exelixis Inc |
MODULATORS OF ALK PROTEIN (ANAPLASTIC LYMPHOMA KINASE) AND METHODS OF USE
|
|
US20050090529A1
(en)
|
2003-07-31 |
2005-04-28 |
Pfizer Inc |
3,5 Disubstituted indazole compounds with nitrogen-bearing 5-membered heterocycles, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
|
|
US7884109B2
(en)
|
2005-04-05 |
2011-02-08 |
Wyeth Llc |
Purine and imidazopyridine derivatives for immunosuppression
|
|
JP5161233B2
(ja)
|
2006-10-19 |
2013-03-13 |
ライジェル ファーマシューティカルズ， インコーポレイテッド |
自己免疫疾患の処置のためのｊａｋキナーゼの阻害剤としての２，４−ピリミジンアミン誘導体
|
|
US8648069B2
(en)
|
2007-06-08 |
2014-02-11 |
Abbvie Inc. |
5-substituted indazoles as kinase inhibitors
|
|
KR20150036210A
(ko)
|
2007-06-13 |
2015-04-07 |
인사이트 코포레이션 |
야누스 키나제 억제제（Ｒ）―３―（４―（７Ｈ―피롤로［２，３－ｄ］피리미딘―4―일）―1Ｈ―피라졸―1―일）―３―사이클로펜틸프로판니트릴의 염
|
|
WO2009155565A1
(en)
|
2008-06-20 |
2009-12-23 |
Genentech, Inc. |
Triazolopyridine jak inhibitor compounds and methods
|
|
CN102131389A
(zh)
|
2008-06-20 |
2011-07-20 |
健泰科生物技术公司 |
三唑并吡啶jak抑制剂化合物和方法
|
|
WO2010039825A2
(en)
|
2008-10-01 |
2010-04-08 |
Array Biopharma Inc. |
IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS
|
|
CL2009001884A1
(es)
|
2008-10-02 |
2010-05-14 |
Incyte Holdings Corp |
Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
|
|
JP2010111624A
(ja)
|
2008-11-06 |
2010-05-20 |
Shionogi & Co Ltd |
Ｔｔｋ阻害作用を有するインダゾール誘導体
|
|
WO2010114971A1
(en)
|
2009-04-03 |
2010-10-07 |
Sepracor Inc. |
Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
|
|
CN106420756A
(zh)
|
2009-07-28 |
2017-02-22 |
里格尔药品股份有限公司 |
抑制jak途径的组合物和方法
|
|
LT3001903T
(lt)
|
2009-12-21 |
2018-01-10 |
Samumed, Llc |
1h-pirazolo[3,4-b]piridinai ir jų terapinis panaudojimas
|
|
EP2338888A1
(en)
|
2009-12-24 |
2011-06-29 |
Almirall, S.A. |
Imidazopyridine derivatives as JAK inhibitors
|
|
US9012464B2
(en)
|
2010-11-25 |
2015-04-21 |
Ratiopharm Gmbh |
Salts and polymorphic forms of Afatinib
|
|
US8575336B2
(en)
*
|
2011-07-27 |
2013-11-05 |
Pfizer Limited |
Indazoles
|
|
EP2771340B1
(en)
|
2011-10-25 |
2016-04-13 |
Sanofi |
6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
|
TW201513861A
(zh)
|
2013-01-17 |
2015-04-16 |
Galapagos Nv |
用於治療退化性及發炎疾病之新穎化合物
|
|
AU2014339897A1
(en)
|
2013-10-24 |
2016-04-21 |
Abbvie Inc. |
JAK1 selective inhibitor and uses thereof
|
|
SI3077395T1
(en)
|
2013-12-05 |
2018-03-30 |
Pfizer Inc. |
Pyrrolo(2,3-d)pyrimidinyl, pyrrolo(2,3-b)pyrazinyl and pyrrolo(2,3-d)pyridinyl acrylamides
|
|
EP3943500A1
(en)
|
2014-04-30 |
2022-01-26 |
Agilent Technologies, Inc. |
Phosphorous protecting groups and methods of preparation and use thereof
|
|
KR20170002623A
(ko)
|
2014-05-14 |
2017-01-06 |
화이자 인코포레이티드 |
피라졸로피리딘 및 피라졸로피리미딘
|
|
WO2016026078A1
(en)
|
2014-08-19 |
2016-02-25 |
Changzhou Jiekai Pharmatech Co., Ltd. |
Heterocyclic compounds as erk inhibitors
|
|
KR101663277B1
(ko)
|
2015-03-30 |
2016-10-06 |
주식회사 녹십자 |
TNIK, IKKε 및 TBK1 억제제로서의 피라졸계 유도체 및 이를 포함하는 약학적 조성물
|
|
DK3371185T3
(da)
|
2015-11-03 |
2020-11-30 |
Topivert Pharma Ltd |
4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridin og 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepinderivater som janus-kinase-inhibitorer
|
|
UA123633C2
(uk)
*
|
2015-11-03 |
2021-05-05 |
Тереванс Байофарма Ар Енд Ді Айпі, Елелсі |
Сполуки інгібітору jak-кінази для лікування респіраторного захворювання
|
|
WO2017077283A1
(en)
|
2015-11-03 |
2017-05-11 |
Topivert Pharma Limited |
4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridine and 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepine derivatives as janus kinase inhibitors
|
|
WO2018011681A1
(en)
|
2016-07-14 |
2018-01-18 |
Pfizer Inc. |
Novel pyrimidine carboxamides as inhibitors of vanin-1 enzyme
|
|
WO2018165392A1
(en)
|
2017-03-09 |
2018-09-13 |
Theravance Biopharma R&D Ip, Llc |
Jak inhibitors containing a 4-membered heterocyclic amide
|
|
KR20200003121A
(ko)
|
2017-05-01 |
2020-01-08 |
세라밴스 바이오파마 알앤디 아이피, 엘엘씨 |
Jak 저해제 화합물의 결정형
|
|
WO2018204233A1
(en)
|
2017-05-01 |
2018-11-08 |
Theravance Biopharma R&D Ip, Llc |
Methods of treatment using a jak inhibitor compound
|
|
AR111495A1
(es)
|
2017-05-01 |
2019-07-17 |
Theravance Biopharma R&D Ip Llc |
Compuestos de imidazo-piperidina fusionada como inhibidores de jak
|
|
KR102032418B1
(ko)
|
2017-06-15 |
2019-10-16 |
한국화학연구원 |
접합 피리미딘 유도체, 이의 제조방법 및 이를 유효성분으로 포함하는 브루톤티로신 키나제 활성 관련 질환의 예방 또는 치료용 약학적 조성물
|
|
JP2021535176A
(ja)
|
2018-09-04 |
2021-12-16 |
セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー |
Ｊａｋ阻害剤およびその中間体を調製するためのプロセス
|
|
FI3837258T3
(fi)
|
2018-09-04 |
2024-05-27 |
Theravance Biopharma R&D Ip Llc |
Dimetyyliaminoatsetidiiniamideja jak-estäjinä
|
|
UA127328C2
(uk)
|
2018-09-04 |
2023-07-19 |
Тереванс Байофарма Ар Енд Ді Айпі, Елелсі |
5-7-членні гетероциклічні аміди як інгібітори jak
|
|
KR20210084512A
(ko)
|
2018-10-29 |
2021-07-07 |
세라밴스 바이오파마 알앤디 아이피, 엘엘씨 |
Jak 억제제로서 2-아자비시클로 헥산 화합물
|
|
HUE067145T2
(hu)
|
2019-02-25 |
2024-10-28 |
Henan Medinno Pharmaceutical Tech Co Ltd |
JAK inhibitor vegyület és alkalmazása
|
|
WO2020181034A1
(en)
|
2019-03-05 |
2020-09-10 |
Incyte Corporation |
Jak1 pathway inhibitors for the treatment of chronic lung allograft dysfunction
|
|
CN112279848A
(zh)
|
2019-07-25 |
2021-01-29 |
四川海思科制药有限公司 |
一种泛JAKs抑制剂及其用途
|
|
JP7580136B2
(ja)
*
|
2019-12-30 |
2024-11-11 |
路良 |
Ｊａｋ阻害剤化合物及びその使用
|
|
WO2022204473A1
(en)
|
2021-03-26 |
2022-09-29 |
Theravance Biopharma R&D Ip, Llc |
Crystalline form of a dihydrochloride salt of a jak inhibitor compound
|